Acquisition - December 21, 2020
Calliditas now controls 86.2% of the shares in Genkyotex
Calliditas has announced the final outcome of simplified mandatory offer to the shareholders of Genkyotex. Calliditas Therapeutics submitted a simplified public mandatory offer to the shareholders of Genkyotex on 26 November 2020. After the end of the acceptance period on December 11, Calliditas now controls 86.2 percent of the shares in Genkyotex. Calliditas acquired 7,236,515 […]
Acquisition - December 14, 2020
Investcorp acquires Sanos Group
Based in Denmark, Sanos is a global Contract Research Organization providing services to pharma, biotech and research organizations to help plan and conduct clinical trials. Sanos Group consists of a CRO specialized in osteoarthritis (“OA”) and a Site Management Organization (“SMO”) with a broader indication range focusing on lifestyle and age-related diseases. Sanos’ scientific leadership […]
Acquisition - December 14, 2020
AstraZeneca to acquire Alexion in USD 39 billion deal
AstraZeneca and Alexion Pharmaceuticals have entered into a definitive agreement for AstraZeneca to acquire Alexion. Alexion shareholders will receive USD 60 in cash and 2.1243 AstraZeneca American Depositary Shares (ADSs) (each ADS representing one-half of one (1/2) ordinary share of AstraZeneca, as evidenced by American Depositary Receipts (ADRs)) for each Alexion share. Based on AstraZeneca’s […]
Acquisition - December 7, 2020
LINK Medical acquires IRW Consulting
LINK Medical has announced the acquisition of IRW Consulting AB, a Nordic CRO with more than 20 years of experience in clinical research outsourcing. With this acquisition LINK Medical will continue growing and strengthening its position in the Nordics while improving its already strong offerings and increasing its clinical operations capabilities in the region, the […]
Acquisition - December 1, 2020
AstraZeneca divests Crestor to Grünenthal in Europe
AstraZeneca has agreed to sell the rights to Crestor (rosuvastatin) and associated medicines in over 30 countries in Europe, except the UK and Spain, to Grünenthal. Crestor is a statin approved for the treatment of dyslipidaemia and hypercholesterolaemia. “This agreement supports the management of our mature medicines to enable reinvestment into the pipeline and bringing […]
Acquisition - November 19, 2020
Immunicum acquires all shares in DCprime
Immunicum has entered into an agreement with Van Herk Investments B.V. to acquire all of the shares in DCprime B.V., a Dutch clinical stage company developing cancer relapse vaccines aimed to reduce tumor recurrence. Merging the complementary allogeneic dendritic cell biology approaches of both companies will enable Immunicum to further build and strengthen its position […]
